What are the risk factors for gynecomastia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 27, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Risk Factors for Gynecomastia

The most significant risk factors for gynecomastia include hormonal imbalances (increased estrogen-to-androgen ratio), medication use, underlying medical conditions, and genetic predisposition. 1, 2

Primary Risk Factors

Physiologic Causes

  • Puberty - occurs in approximately 50% of adolescent males due to temporary hormonal fluctuations 3
  • Aging - common in older men due to declining testosterone levels 4
  • Neonatal period - transient gynecomastia in newborns from maternal estrogens 3

Medications

  • Spironolactone - risk increases in a dose-dependent manner with onset varying from 1-2 months to over a year 5
  • Cimetidine - causes gynecomastia in approximately 4% of patients with pathological hypersecretory states and 0.3-1% in other patients 6
  • Other common medications:
    • Androgen receptor blockers
    • Estrogen therapy
    • Anti-androgens used in prostate cancer treatment 1

Medical Conditions

  • Hormonal disorders:
    • Hypogonadism (primary or secondary)
    • Hyperthyroidism
    • Hyperprolactinemia 1
  • Systemic diseases:
    • Liver cirrhosis
    • Renal insufficiency
    • Malnutrition 7, 4

Genetic and Physical Factors

  • Klinefelter syndrome significantly increases risk (RR 24.7) 8
  • Pre-existing gynecomastia increases risk of further development 1
  • Obesity (contributes to pseudogynecomastia but can also increase true gynecomastia through peripheral conversion of androgens to estrogens) 1

Special Risk Considerations

Genetic Predisposition

  • BRCA2 mutation carriers have significantly higher risk of male breast cancer and gynecomastia 8
  • Family history of male breast disorders increases risk 8

Lifestyle Factors

  • Alcohol consumption (especially in the context of liver disease) 4
  • Use of illicit drugs (particularly marijuana and anabolic steroids) 3
  • Exposure to exogenous estrogens (environmental or occupational) 4

Risk Assessment Algorithm

  1. Evaluate medication history:

    • Review all current medications, particularly those known to cause gynecomastia 5, 6
    • Consider temporal relationship between medication initiation and onset of gynecomastia 1
  2. Assess for underlying medical conditions:

    • Evaluate for signs of hypogonadism, thyroid disease, liver disease, or renal dysfunction 4
    • Consider hormonal testing in cases without obvious cause 1
  3. Consider genetic factors:

    • Assess family history of breast disorders 8
    • Consider genetic testing in appropriate cases, especially with family history of male breast cancer 8
  4. Evaluate physical characteristics:

    • Differentiate true gynecomastia from pseudogynecomastia 1
    • Assess for bilateral (50% of cases) versus unilateral presentation 1

Clinical Implications

  • Gynecomastia is often benign but can cause significant psychological distress and physical discomfort 2
  • Risk of male breast cancer is higher in patients with BRCA2 mutations and Klinefelter syndrome 8
  • Early identification of underlying causes allows for targeted intervention 9
  • Gynecomastia persisting beyond 12 months often becomes fibrotic and less responsive to medical therapy 4

Common Pitfalls to Avoid

  • Failing to distinguish between true gynecomastia and pseudogynecomastia, especially in obese patients 1
  • Overlooking medication-induced gynecomastia, which is potentially reversible 5, 6
  • Unnecessary imaging in clear cases of gynecomastia can lead to additional unnecessary benign biopsies 1
  • Missing rare but serious underlying causes such as testicular tumors or adrenal pathology 4

References

Guideline

Gynecomastia Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Gynecomastia: Clinical evaluation and management.

Indian journal of endocrinology and metabolism, 2014

Research

Gynecomastia.

American family physician, 2012

Research

Gynaecomastia--pathophysiology, diagnosis and treatment.

Nature reviews. Endocrinology, 2014

Research

Gynecomastia.

Endocrinology and metabolism clinics of North America, 1994

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.